Koninklijke Philips (RYLPF) EBT Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Koninklijke Philips | - | - | 2.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 617.00 |
| Dec 31, 2025 | -297.00 |
| Sep 30, 2025 | 356.00 |
| Jun 30, 2025 | 448.00 |
| Mar 31, 2025 | 292.00 |
| Dec 31, 2024 | 528.00 |
| Sep 30, 2024 | -1,258.00 |
| Jun 30, 2024 | 755.00 |
| Mar 31, 2024 | -2,731.00 |
| Dec 31, 2023 | -1,648.00 |
| Sep 30, 2023 | -1,549.00 |
| Jun 30, 2023 | -321.00 |
| Mar 31, 2023 | -1,937.00 |
| Dec 31, 2022 | -3,014.00 |
| Sep 30, 2022 | -4,565.00 |
| Jun 30, 2022 | -1,081.00 |
| Mar 31, 2022 | -1,032.00 |
| Dec 31, 2021 | 269.00 |
| Sep 30, 2021 | -336.74 Mn |
| Jun 30, 2021 | -202.00 |
| Mar 31, 2021 | -361.00 |
| Dec 31, 2020 | 954.00 |
| Sep 30, 2020 | 299.00 |
| Jun 30, 2020 | -12.00 |
| Mar 31, 2020 | -173.00 |
| Dec 31, 2019 | -585.00 |
| Mar 31, 2018 | -114.00 |
| Dec 31, 2017 | -314.00 |
| Sep 30, 2017 | 212.00 |
| Jun 30, 2017 | 131.00 |
| Mar 31, 2017 | -28.00 |
| Dec 31, 2016 | 944.00 |
| Sep 30, 2016 | 336.75 Mn |
| Jun 30, 2016 | 1,104.00 |
| Mar 31, 2016 | -373.00 |
| Dec 31, 2015 | -873.00 |
| Sep 30, 2015 | -86.00 |
| Jun 30, 2015 | -7.00 |
| Mar 31, 2015 | -491.00 |
| Dec 31, 2014 | -374.00 |